Consequently, in CD4+ T cells with SHP2 knockout, STAT1 is hyper-activated, triggering increased Th1 differentiation and IFN-γ production, which further enhances the activity of CD8+ CTLs for anti-tumor immunity [83]. The gene discussed is CD8A; the disease is neoplasm.